A phase I dose-escalation and expansion trial of intratumorally administered CV8102, alone and in combination with anti-PD-1 in patients with advanced solid tumours

Krauss J, Eigentler T, Schreiber J, Weishaupt C, Terheyden P, Heinzerling L, Mohr P, Weide B, Ochsenreither S, Gutzmer R, Becker JC, Kiecker F, Funkner F, Heidenreich R, Kays SK, Klinkhardt U, Gnad-Vogt US, Scheel B, Schoenborn-Kellenberger O, Seibel T (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Annals of Oncology Elsevier

Publisher: OXFORD UNIV PRESS

City/Town: OXFORD

Pages Range: 191-+

Conference Proceedings Title: ANNALS OF ONCOLOGY

Event location: Barcelona ES

DOI: 10.1093/annonc/mdz244.071

Authors with CRIS profile

Lucie Heinzerling Department of Dermatology

Involved external institutions

Medizinische Hochschule Hannover (MHH) / Hannover Medical School DE Germany (DE) Universitätsklinikum Heidelberg DE Germany (DE) Universitätsklinikum Tübingen DE Germany (DE) Charité - Universitätsmedizin Berlin DE Germany (DE) Boehringer Ingelheim Pharma GmbH & Co. KG DE Germany (DE) CureVac GmbH DE Germany (DE) Cogitars GmbH DE Germany (DE) Deutsches Krebsforschungszentrum (DKFZ) DE Germany (DE) Ruprecht-Karls-Universität Heidelberg DE Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) DE Germany (DE) Universitätsklinikum Münster DE Germany (DE)

How to cite

APA:

Krauss, J., Eigentler, T., Schreiber, J., Weishaupt, C., Terheyden, P., Heinzerling, L.,... Seibel, T. (2019). A phase I dose-escalation and expansion trial of intratumorally administered CV8102, alone and in combination with anti-PD-1 in patients with advanced solid tumours. In ANNALS OF ONCOLOGY (pp. 191-+). Barcelona, ES: OXFORD: OXFORD UNIV PRESS.

MLA:

Krauss, J., et al. "A phase I dose-escalation and expansion trial of intratumorally administered CV8102, alone and in combination with anti-PD-1 in patients with advanced solid tumours." Proceedings of the 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona OXFORD: OXFORD UNIV PRESS, 2019. 191-+.

BibTeX: Download